Provided by Tiger Trade Technology Pte. Ltd.

Xenon Pharmaceuticals

60.00
-0.2200-0.37%
Post-market: 60.300.3000+0.50%16:23 EDT
Volume:418.79K
Turnover:25.11M
Market Cap:5.80B
PE:-12.75
High:61.16
Open:60.48
Low:59.54
Close:60.22
52wk High:72.66
52wk Low:35.60
Shares:96.64M
Float Shares:95.45M
Volume Ratio:0.58
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7061
EPS(LYR):-4.3646
ROE:-43.62%
ROA:-28.02%
PB:4.67
PE(LYR):-13.75

Loading ...

Xenon Pharmaceuticals: Buy Rating Backed by Superior X-TOLE2 Phase 3 Results and Commercial Upside for Azetukalner in Focal Epilepsy

TIPRANKS
·
Mar 10

Wells Fargo Sticks to Their Buy Rating for Xenon (XENE)

TIPRANKS
·
Mar 10

Wedbush Adjusts PT on Xenon Pharmaceuticals to $64 From $47, Maintains Outperform Rating

MT Newswires Live
·
Mar 10

Small U.S. Stocks Close Up; Xenon Pharmaceuticals Climbs Highest

Dow Jones
·
Mar 10

Xenon Pharmaceuticals announces $500M common shares offering

TIPRANKS
·
Mar 10

Xenon Pharmaceuticals Inc - Commences $500 Mln Underwritten Public Offering

THOMSON REUTERS
·
Mar 10

Press Release: Xenon Pharmaceuticals Announces Proposed Public Offering

Dow Jones
·
Mar 10

Top Midday Gainers

MT Newswires Live
·
Mar 10

A Look At Xenon Pharmaceuticals (XENE) Valuation After Recent Share Price Drift Without Clear Catalyst

Simply Wall St.
·
Mar 10

Raymond James says rival readout gives Biohaven’s Opakalim room to differentiate

TIPRANKS
·
Mar 10

Xenon Pharmaceuticals Is Maintained at Outperform by Baird

Dow Jones
·
Mar 10

Xenon Pharmaceuticals: Blockbuster Potential for Azetukalner After Outperforming Phase 3 Epilepsy Data Drives Target Hike to $80

TIPRANKS
·
Mar 10

Xenon Pharmaceuticals: Azetuklaner’s Strong Phase III Data and Blockbuster Potential Underscore Undervalued Buy Opportunity

TIPRANKS
·
Mar 10

Xenon Pharmaceuticals price target raised to $97 from $63 at Baird

TIPRANKS
·
Mar 10

What's Going On With Biohaven Stock On Monday?

Benzinga_recent_news
·
Mar 09

BUZZ-U.S. STOCKS ON THE MOVE-Biotechs, Agilent, Dow

Reuters
·
Mar 09

Xenon Pharmaceuticals Up Over 45%, on Track for Record High Close -- Data Talk

Dow Jones
·
Mar 09

Xenon Pharmaceuticals rises 41.8%

TIPRANKS
·
Mar 09

Xenon Pharmaceuticals Soars Over 42% at Opening on Positive Phase 3 Epilepsy Drug Results

Stock News
·
Mar 09

BUZZ-U.S. STOCKS ON THE MOVE-Hims & Hers, Live Nation, NovaBridge

Reuters
·
Mar 09